Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislaw R Burzynski

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Medical Hypotheses|March 5, 2003
Gene silencing--a new theory of agingStanislaw R Burzynski
Integrative Cancer Therapies|March 24, 2004
The present state of antineoplaston research (1)Stanislaw R Burzynski
Paediatric Drugs|June 16, 2006
Treatments for astrocytic tumors in children: current and emerging strategiesStanislaw R Burzynski
Medical Hypotheses|November 10, 2004
Aging: gene silencing or gene activation?Stanislaw R Burzynski
Journal of Pediatric Hematology/Oncology|October 19, 2013
Long-term survival (>13 years) in a child with recurrent diffuse pontine gliosarcoma: a case reportStanislaw R Burzynski, Tomasz J Janicki, Gregory S Burzynski, et al.
Integrative Cancer Therapies|February 18, 2006
Targeted therapy with antineoplastons A10 and AS2-1 of high-grade, recurrent, and progressive brainstem gliomaStanislaw R Burzynski, Tomasz J Janicki, Robert A Weaver, et al.
Pediatric Neurosurgery|May 1, 2015
Complete response and long-term survival (>20 years) of a child with tectal glioma: a case reportStanislaw R Burzynski, Gregory S Burzynski, Tomasz J Janicki, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|April 11, 2014
The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem gliomaStanislaw R Burzynski, Tomasz J Janicki, Gregory S Burzynski, et al.
Integrative Cancer Therapies|May 25, 2005
Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1Stanislaw R Burzynski, Robert A Weaver, Tomasz Janicki, et al.
Integrative Cancer Therapies|August 18, 2004
Long-term survival and complete response of a patient with recurrent diffuse intrinsic brain stem glioblastoma multiformeStanislaw R Burzynski, Robert I Lewy, Robert Weaver, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Medical Hypotheses|March 5, 2003
Gene silencing--a new theory of agingStanislaw R Burzynski
Integrative Cancer Therapies|March 24, 2004
The present state of antineoplaston research (1)Stanislaw R Burzynski
Paediatric Drugs|June 16, 2006
Treatments for astrocytic tumors in children: current and emerging strategiesStanislaw R Burzynski
Medical Hypotheses|November 10, 2004
Aging: gene silencing or gene activation?Stanislaw R Burzynski
Journal of Pediatric Hematology/Oncology|October 19, 2013
Long-term survival (>13 years) in a child with recurrent diffuse pontine gliosarcoma: a case reportStanislaw R Burzynski, Tomasz J Janicki, Gregory S Burzynski, et al.
Integrative Cancer Therapies|February 18, 2006
Targeted therapy with antineoplastons A10 and AS2-1 of high-grade, recurrent, and progressive brainstem gliomaStanislaw R Burzynski, Tomasz J Janicki, Robert A Weaver, et al.
Pediatric Neurosurgery|May 1, 2015
Complete response and long-term survival (>20 years) of a child with tectal glioma: a case reportStanislaw R Burzynski, Gregory S Burzynski, Tomasz J Janicki, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|April 11, 2014
The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem gliomaStanislaw R Burzynski, Tomasz J Janicki, Gregory S Burzynski, et al.
Integrative Cancer Therapies|May 25, 2005
Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1Stanislaw R Burzynski, Robert A Weaver, Tomasz Janicki, et al.
Integrative Cancer Therapies|August 18, 2004
Long-term survival and complete response of a patient with recurrent diffuse intrinsic brain stem glioblastoma multiformeStanislaw R Burzynski, Robert I Lewy, Robert Weaver, et al.
Pageof 2